Objective: The number of lowland dwellers traveling at high altitudes has greatly increased in recent decades. Business tra velers flying to La Paz or Lhasa are at risk of altitude illnesses, similarly to miners and soldiers transported to high altitudes. Traveling to high altitude requires adaptation and if this process fails due to too rapid an ascent rate or susceptibility of the climber, acute mountain sickness (AMS) may result. Doctors and nurses in travel clinics, health centers and occupational health care clinics may face patients asking advice on how to plan their trips or manage AMS, or the health care person nel may take part in a travel to high altitude environment. Methods: Two patients, aged 29 and 47 years, who fulfilled the criteria for AMS were studied. The clinical findings and treatment in the field are described including the review of the current recommendations for prevention and treatment of AMS. Results: Both patients developed a severe AMS due to too rapid ascent and their denial of the symptoms. Conclusions: Prevention is the safest and the most efficient method in the care concerning AMS. Realizing the risk of mountain sickness, active inquiry about the symptoms and correctly timed reaction to them, in other words interrupting the ascent or descending, help to reduce and even to prevent the development of serious problems.
Traveling to high altitude requires acclimatization to both lower air pressure and diminished partial pressure of oxy gen [1] . If this process fails, due to too rapid ascent rate or susceptibility of the climber, one or a combination of three illnesses may result: acute mountain sickness (AMS), high altitude cerebral edema (HACE) or high altitude pulmonary edema (HAPE). AMS is the most common of these problems affecting 25% of those who ascend the al titudes of 1850 to 2750 m [2] , 42 % of people at altitudes of 3000 m [1] , and as many as 75% at Mount Kiliman jaro (5984 m) where the most common reason for high prevalence for AMS is the rapid ascent [3] . AMS usually develops after 1-3 days of sojourn at high altitude. If the ascent is halted, AMS usually ceases within 1-2 days, but substantial discomfort and inconvenience are still com mon. The Lake Louise Self-Report Score and Clinical As sessment Score Questionnaire (LLS) is widely used for the diagnosis of AMS [4] . AMS is diagnosed according to a re cent gain in altitude, the presence of headaches and at least one of the following symptoms: gastrointestinal (GI) upset, fatigue, dizziness or insomnia. The symptoms and clinical findings such peripheral edema, the difficulties concerning walking along the straight line or standing and changes in the mental state were graded from 0 to 4, with 0 meaning no symptoms at all, 1-4 meaning mild, moderate, severe and extremely severe symptoms, respectively. A sum of the selfreported symptom points equaling 3 or above, includ ing headache, indicated AMS (Table 1 ) [1] . Doctors and nurses in health centers, travel clinics and occupational health care clinics may be approached by patients asking advice on how to plan their trips or treat either themselves or a friend at high altitude, or the health care personnel may take part in an expedition to high al titude environment. In this article, we present two cases of AMS patients and their treatment in the field including the review of the current recommendations for prevention and treatment of AMS. CASE 1. Physical stress, dehydration and too rapid ascent A 29yearold, healthy, nonsmoking and experienced Finnish mountaineer participated in an expedition to a mountain over 8000 m high in Tibet. It took him four days to reach the altitude of 5000 m by car and he spent three days there to acclimatize. He had no previous histo ry of AMS. The heart rate (HR) at rest was 60 per minute and the LLS showed no altitude-related symptoms. There was a 400 m ascent to the next camp, and the distance to be covered was 15 km. The weather was first sunny and warm, later it was cloudy, and at times there was a slight snowfall. The climber drank 1900 ml of fluid during the trek. During the day, he excreted 500 ml of urine. On ar rival at the campsite -at the height of 5425 m -he was accompanied by one fellow climber. He felt a little tired with a slightly slowed coordination, but the camp routines went fast. After putting up the tent, he felt very tired and shivering cold. In the sleeping bag, his body temperature under the arm rose to 37.8°C. He consumed fluids in the form of food and drink -in total 2 400 ml. During the following night, * An individual has acute mountain sickness as assessed by the Lake Louise self-assessment scoring system if they fulfill the following crite ria: 1 -recent ascent at high altitude, 2 -headache present, 3 -the total symptom score above 3 [1, 4] .
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306 CASE 2. Too rapid ascent and denial of the symptoms A 47yearold, nonsmoking and experienced mountain eer, who, however, had not earlier been above the altitude of 4000 m, participated in a car drive in the highlands of Ti bet. The road went to the highlands from 1500 m to a village at 2930 m, where he spent two nights to acclimatize. The next day he got a headache and did not feel well when the expe dition continued the ascent. The patient did not tell anyone about his symptoms. During the following day, the road rose to 4800 m and the headache symptoms increased. Because of the headache, the patient started to take paracetamol (500 mg three times a day) as pain medication. When the doctor of the expedition talked to him, he reported that he was well and had no symptoms of AMS at all. During the fol lowing morning, the man had a severe headache, faintness and moderately strong lightheadedness which impaired his coordination and caused ataxia. The previous night, his sleep had been extremely fragmentary and he had slept only a few hours. SpO 2 was 58% at rest, there were crack les and bubbling in the lung auscultation, HR was 110/min and LLS was 6. At this moment, AMS, HAPE and HACE were diagnosed and the following treatment was initiat ed: 250 mg of acetazolamide, 20 mg of nifedi pine and 8 mg of dexamethason once, and then 4 mg every eight hours. Because of restricted oxygen capacity, oxygen was given to him at intervals of a couple of hours for 20 min as adjuvant care 4 l/min. The patient's urgent evacuation was necessary but since the vehicles broke down then, the evacuation was delayed by 2 days. During the day, the situation deteriorat ed. Based on the auscultation and percussion, it was deter mined that the right lung was half full and the left lung was full of fluid. SpO 2 was still 58% in spite of the treatment, the skin was extremely pale and the lips cyanotic. There was no fever. Urine excretion was at a standstill. Lake Louise score was 8. In the evening, the man's health improved a little, even though SpO 2 was still only 68%. He could not lie down because of an increase in dyspnea, so he had to spend his he did not urinate at all. On falling asleep at 8:00 p.m. his HR was 120/min and respiratory rate (RR) -30/min. After he fell asleep, his companion soon perceived perio dic breathing caused by high altitude which is similar to CheyneStokes type breathing, and at 10:00 p.m., his HR rose to 130/min. Furthermore, the shortness of breath and the feeling of compression were found in the chest. The breath ing sounds were bubbling when auscultated. The arte rial oxygen saturation (SpO 2 ) was 59%, LLS 8 and AMS and HAPE were diagnosed. 250 mg of Asetatzolamide and 20 mg of nifedipine began to be administered ev ery eight hours and the development of the situation was monitored during the night at intervals of 1-2 hours. The subject drank 600 ml of water during the night. When the symptoms eased at 2:00 a.m., with RR 21/min and HR -115/min, he was given permission to sleep in spite of a slight headache. In the morning, he was feel ing well, except for slight faintness and headache. He ex creted 750 ml of urine, his RR was 20/min, SpO 2 -71% and HR -105/min. At lung auscultation no sounds of edema were heard at any stage. 8 points on the LLS scale indicated moderate mountain sickness and the pa tient should have been treated with descent, oxygen or a portable hyperbaric chamber. At this camp, they had no oxygen treatment or evacuation facilities. They com municated via satphone with their travel clinic. Accord ing to the doctor's instructions, he stayed at this altitude because descent was not possible. After two days' rest, all symptoms disappeared, SpO 2 was 74%, HR -95/min and he continued four kilometers on to the next camp, which was 200 m higher and had better facilities. The ascent went without problems and no further symptoms of AMS or HAPE occurred. The medication was discontinued af ter three nights without any problems in a 5650 m camp when his HR was 75/min, RR 18/min and SpO 2 -85%. After this, the subject participated in the expedition nor mally without any restrictions. Table 2 and nifedipine were discontinued. Four weeks later, the pa tient was totally symptomfree and healthy. trip is made in a hygiene environment different from the travelers' country of origin and diarrhea and vomiting may disturb the fluid and energy balance of the body [8] . Lack of oxygen makes logical thinking more difficult, which may predispose one to serious miscalculations [9] . Young healthy males are often at the greatest risks of AMS as they may ascend too fast too high because of their good physical con dition. Physically heavy exertions, such as downhill skiing or climbing, are often begun before the body has had time to adapt at certain altitude [10] . Traveling in groups gives extra security, but in some cases there may occur an unwise com petitive spirit. In a group, the objective analysis and report ing of the climber's own feelings may be forgotten and prob lems can accumulate when the climbers continue upwards. Tight schedules are also dangerous. It would be good to include in the schedules extra days for rest and adaptation. Prevention is the safest and the most efficient method in the care of AMS. The symptoms may not be easily noticed, and thus curative measures may be delayed. Remedying the situation requires radical actions such as interrupting When climbing the altitudes over 3000 m, the current re commendations are to ascend only 300-600 m per day and to have an acclimatization day for every 600-1200 m of altitude gained [1, 5] , so that the body can adapt to the al titude. In practice, travelers and climbers usually ascend considerably faster than commended [3] . Slight symptoms of AMS may become more serious if the symptoms and warning signs are ignored. Continuing the ascent may lead to HAPE or HACE, which are life-threatening condi tions. There have been HAPE cases at 1400-2400 m even though, usually, these problems are found at altitudes over 2500 m [6] . The symptoms may increase throughout a few hours and the patient may no longer be capable of descending himself. During the ascent, one of the most important actions to avoid mountain sickness is to have sufficient food and drink intake [7] . Lack of oxygen causes hyperventilation, and thus dehydration increases while breathing [8] . The adequate amount of fluid at high altitude is not precisely defined, but 5-7 l of fluids per day are usually consumed. Often, the Table 2 .
